Released on: December 31, 2021 Deadline extended to: June 30, 2023 This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. This activity is supported by an independent grant from Alexion Pharmaceuticals. Credit Available Physicians— maximum of 0.75 AMA PRA Category 1 Credit(s)™ Nurses— maximum of 0.75 contact …
Category Archives: Expired
Cannabis and MS: Helping Patients Understand Risks and Benefits Session 1: Fundamentals of Cannabis
CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 1: FUNDAMENTALS OF CANNABIS REISSUANCE DATE: October 31, 2021 VALID FOR CREDIT THROUGH: October 31, 2022 SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with MS who use cannabis. However, numerous surveys indicate that …
Cannabis and MS: Helping Patients Understand Risks and Benefits Session 2: Cannabis as an Herbal Medicine – Efficacy/Side Effect Considerations and Case Studies
CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 2: CANNABIS AS AN HERBAL MEDICINE – EFFICACY/SIDE EFFECT CONSIDERATIONS AND CASE STUDIES REISSUANCE DATE: October 31, 2021 VALID FOR CREDIT THROUGH: October 31, 2022 SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with …
Cannabis and MS: Helping Patients Understand Risks and Benefits Session 3: Pharmacology and Interactions, Trial Data, DMTs, and Case Studies
CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 3: PHARMACOLOGY AND INTERACTIONS, TRIAL DATA, DMTs, AND CASE STUDIES REISSUANCE DATE: October 31, 2021 VALID FOR CREDIT THROUGH: October 31, 2022 SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with MS who use …
Science and Self: Monitoring Response to MS Treatment with Biomarkers and Patient-Reported Outcomes
Release: 12/15/21 Expiration: 12/15/22 This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. This activity is supported by independent grants from Bristol Myers Squibb and Novartis Pharmaceuticals Corporation. Credit Available Physicians — maximum of 1.0 AMA PRA Category 1 Credits™ Nurses — 1.0 contact hours of continuing nursing education (1.0 in the area of pharmacology) Pharmacists — …
Right Treatment, Right Time: A Comprehensive Curriculum on Individualized Treatment Approaches for Multiple Sclerosis – Treatment Considerations for MS in a Crowded Landscape
Released: December 1, 2021 Expires: December 1, 2022 An informative webinar designed to meet the educational needs of neurology physicians, nurse practitioners, PAs, pharmacists, and other healthcare professionals involved in the care of patients living with MS. Program Overview This timely webinar provides an overview of the efficacy, safety, side effects, and immune system impact …
Medical Crossfire®: Sequencing of Disease-Modifying Therapies—Optimizing Outcomes in Patients With Multiple Sclerosis
December 9, 2021 1:00-2:00pm EST Live, Interactive Webcast! Overview Multiple sclerosis (MS) is an inflammatory disorder of the central nervous system characterized by demyelination and neurodegenerative progression. Most patients with MS experience relapses and remission of neurological symptoms, especially early in the disease course. Advances in understanding of the immune mechanisms that contribute to MS …
IJMSC: NARCOMS and Other Registries in Multiple Sclerosis: Issues and Insights
Release Date: December 1, 2021 Valid for Credit Through: December 1, 2022 NARCOMS and Other Registries in Multiple Sclerosis: Issues and Insights Ruth Ann Marrie, MD, PhD; Gary R. Cutter, PhD; Robert J. Fox, MD, MSc; Timothy Vollmer, MD; Tuula Tyry, PhD; Amber Salter, PhD Target Audience: The target audience for this activity is physicians, …
Continue reading “IJMSC: NARCOMS and Other Registries in Multiple Sclerosis: Issues and Insights”
Novel Treatment: Upgrading the Standard of Care for Neuromyelitis Optica Spectrum Disorder (NMOSD)
RELEASE DATE: November 18, 2021 EXPIRATION DATE: November 18, 2022 FACULTY Dean Wingerchuk, MD, MSc, FRCP(C) Professor and Chair Department of Neurology Mayo Clinic Phoenix/Scottsdale, Arizona Claudia Lucchinetti, MD Chair, Department of Neurology Dean, Clinical and Translational Science Mayo Clinic Rochester, Minnesota PROGRAM OVERVIEW This enduring activity will cover the treatment of patients with neuromyelitis optica spectrum …
Science and Self: Monitoring Response to MS Treatment with Biomarkers and Patient Reported Outcomes
Live Webinar Wednesday, December 1, 2021 7:00 – 8:00 pm EST This timely live webinar will provide an overview of the efficacy, safety, side effects, and immune system impact of MS disease-modifying therapies. With featured speaker: Edward J. Fox, MD, PhD Director, MS Clinic of Central Texas Central Texas Neurology Consultants Clinical Associate Professor, University …